뒤로
Rani Therapeutics Holdings Inc(RANI) 가격
RANI 주가 차트
RANI 주가 예측
Rani Therapeutics Holdings Inc
$1.22
10.9%
$0.11
종가: Feb 06, 16:00:00 GMT-5
$1.2
-1.63%
$-0.02
애프터마켓: Feb 06, 20:49:32 GMT-5
주요 통계
이전 종가
$1.1
시가
$1.12
일일 범위
$1.11 - $1.27
52주 범위
$0.387 - $3.87
거래량
969.3K
평균 거래량
3.4M
EPS(TTM)
-0.79
배당수익률
--
시가총액
$145.8M
RANI란 무엇인가요?
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company is headquartered in San Jose, California and currently employs 105 full-time employees. The company went IPO on 2021-07-30. The firm has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. The company has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. The company is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).